N/A
Manufactured by Alembic Pharmaceuticals Inc.
18,067 FDA adverse event reports analyzed
Last updated: 2026-04-15
FORMOTEROL FUMARATE is a medication tracked in the FDA Adverse Event Reporting System (FAERS), manufactured by Alembic Pharmaceuticals Inc.. The most commonly reported adverse reactions for FORMOTEROL FUMARATE include DYSPNOEA, ASTHMA, COUGH, WHEEZING, PNEUMONIA. This page provides a comprehensive breakdown of reported side effects, safety signals, patient demographics, and AI-powered safety analysis for FORMOTEROL FUMARATE.
Out of 3,238 classified reports for FORMOTEROL FUMARATE:
The FDA classifies an adverse event as “serious” if it results in death, hospitalization, disability, congenital anomaly, or requires intervention to prevent permanent damage.
Demographics reflect voluntary FDA adverse event reporting patterns and may not represent the full patient population.
This profile reflects 18,067 FDA FAERS reports that mention FORMOTEROL FUMARATE. Reporting is voluntary and does not prove that the drug caused any listed event.
Frequently reported terms in FAERS include DYSPNOEA, ASTHMA, COUGH, WHEEZING, PNEUMONIA, THERAPEUTIC PRODUCT EFFECT INCOMPLETE. Rankings reflect reporting volume in this dataset, not confirmed side effect rates in the general population.
Labeling and FAERS entries often list Alembic Pharmaceuticals Inc. in connection with FORMOTEROL FUMARATE. Always verify the specific product and NDC with your pharmacist.